头颈部鳞状细胞癌-话题@MedSci

#头颈部鳞状细胞癌#

55篇内容 | 4167人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1297690, encodeId=407f129e690f4, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=CLIN CANCER RES：NOTCH4-HEY1通路诱导头颈部鳞状细胞癌上皮间质化, objectType=article, longId=130634, objectId=6672130634b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6672130634b8, replyNumber=0, likeNumber=128, createdTime=2018-02-27, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6672130634b8, moduleTitle=CLIN CANCER RES：NOTCH4-HEY1通路诱导头颈部鳞状细胞癌上皮间质化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6672130634b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297689, encodeId=d8d6129e68947, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Ann Oncol：顺铂+西妥昔单抗+再放疗对于复发性或第二原发性头颈部鳞状细胞癌患者可行, objectType=article, longId=127049, objectId=a3f612e04938, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3f612e04938, replyNumber=0, likeNumber=103, createdTime=2018-01-21, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3f612e04938, moduleTitle=Ann Oncol：顺铂+西妥昔单抗+再放疗对于复发性或第二原发性头颈部鳞状细胞癌患者可行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3f612e04938)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297688, encodeId=be90129e68868, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Ann Oncol：顺铂+西妥昔单抗+再放疗对于复发性或第二原发性头颈部鳞状细胞癌患者可行, objectType=article, longId=127050, objectId=34ed12e050b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34ed12e050b3, replyNumber=0, likeNumber=98, createdTime=2018-01-21, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34ed12e050b3, moduleTitle=Ann Oncol：顺铂+西妥昔单抗+再放疗对于复发性或第二原发性头颈部鳞状细胞癌患者可行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34ed12e050b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297687, encodeId=e0b4129e68789, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Oral Oncol：头颈部鳞状细胞癌突变的主要来源-APOBEC, objectType=article, longId=120745, objectId=cd1d120e45f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd1d120e45f6, replyNumber=0, likeNumber=86, createdTime=2017-11-21, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd1d120e45f6, moduleTitle=Oral Oncol：头颈部鳞状细胞癌突变的主要来源-APOBEC, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd1d120e45f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297686, encodeId=e803129e6863c, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=BJC：SKLB188抑制头颈部鳞状细胞癌生长, objectType=article, longId=112145, objectId=b4e91121456c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4e91121456c, replyNumber=0, likeNumber=93, createdTime=2017-09-08, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4e91121456c, moduleTitle=BJC：SKLB188抑制头颈部鳞状细胞癌生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4e91121456c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297685, encodeId=39fe129e68558, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Eur Radiol：FDG-PET/MRI联合DWI检出头颈部鳞状细胞癌放化疗后局部复发的价值, objectType=article, longId=111018, objectId=0344111018cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0344111018cb, replyNumber=0, likeNumber=81, createdTime=2017-08-28, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0344111018cb, moduleTitle=Eur Radiol：FDG-PET/MRI联合DWI检出头颈部鳞状细胞癌放化疗后局部复发的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0344111018cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297684, encodeId=ecc1129e684cd, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Lancet Oncol：纳武单抗：复发性/转移性头颈部鳞状细胞癌患者的福音？, objectType=article, longId=110417, objectId=1be011041ef9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1be011041ef9, replyNumber=0, likeNumber=85, createdTime=2017-08-23, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1be011041ef9, moduleTitle=Lancet Oncol：纳武单抗：复发性/转移性头颈部鳞状细胞癌患者的福音？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1be011041ef9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297683, encodeId=df00129e683bd, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Ann Oncol：局部晚期头颈部鳞状细胞癌的HPV状态是否能决定其有效化疗方案（EORTC 24971研究的亚组分析）, objectType=article, longId=106824, objectId=70fc106824cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70fc106824cf, replyNumber=0, likeNumber=101, createdTime=2017-07-28, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70fc106824cf, moduleTitle=Ann Oncol：局部晚期头颈部鳞状细胞癌的HPV状态是否能决定其有效化疗方案（EORTC 24971研究的亚组分析）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70fc106824cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297682, encodeId=1b30129e682a8, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=CLIN CHEM：血液中的游离循环甲基化DNA用于头颈部鳞状细胞癌患者的诊断，分期，预后和监测, objectType=article, longId=106782, objectId=af53106e82fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af53106e82fb, replyNumber=0, likeNumber=99, createdTime=2017-07-28, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af53106e82fb, moduleTitle=CLIN CHEM：血液中的游离循环甲基化DNA用于头颈部鳞状细胞癌患者的诊断，分期，预后和监测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af53106e82fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297681, encodeId=9aa9129e681c5, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=CLIN CANCER RES：c-Fos可以增强头颈部鳞状细胞癌肿瘤干细胞样细胞特性, objectType=article, longId=104589, objectId=057f10458985, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=057f10458985, replyNumber=0, likeNumber=93, createdTime=2017-07-06, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=057f10458985, moduleTitle=CLIN CANCER RES：c-Fos可以增强头颈部鳞状细胞癌肿瘤干细胞样细胞特性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=057f10458985)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297680, encodeId=68da129e680c8, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=CLIN CANCER RES：Motolimod联合西妥昔单抗治疗复发或转移性头颈部鳞状细胞癌, objectType=article, longId=99868, objectId=a6ba99868a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6ba99868a9, replyNumber=0, likeNumber=140, createdTime=2017-05-28, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6ba99868a9, moduleTitle=CLIN CANCER RES：Motolimod联合西妥昔单抗治疗复发或转移性头颈部鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6ba99868a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297679, encodeId=987c129e67933, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=JAMA Oncology：头颈部鳞状细胞癌KRAS变异与西妥昔单抗反应, objectType=article, longId=98232, objectId=5bb1982322d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bb1982322d, replyNumber=0, likeNumber=94, createdTime=2017-05-10, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bb1982322d, moduleTitle=JAMA Oncology：头颈部鳞状细胞癌KRAS变异与西妥昔单抗反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bb1982322d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297678, encodeId=6219129e67887, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=百时美Opdivo获欧盟CHMP推荐批准，将成欧洲治疗头颈部鳞状细胞癌（SCCHN）的肿瘤免疫疗法, objectType=article, longId=94071, objectId=2032940e105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2032940e105, replyNumber=0, likeNumber=89, createdTime=2017-03-31, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2032940e105, moduleTitle=百时美Opdivo获欧盟CHMP推荐批准，将成欧洲治疗头颈部鳞状细胞癌（SCCHN）的肿瘤免疫疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2032940e105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297677, encodeId=53d3129e677fb, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=2016 CCO指南：头颈部鳞状细胞癌的系统治疗, objectType=article, longId=82183, objectId=ed1a82183a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed1a82183a8, replyNumber=0, likeNumber=54, createdTime=2016-11-13, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed1a82183a8, moduleTitle=2016 CCO指南：头颈部鳞状细胞癌的系统治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed1a82183a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297676, encodeId=ec92129e6764c, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=2016头颈部鳞状细胞癌颈淋巴结转移处理的专家共识发布, objectType=article, longId=76789, objectId=077be678903, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=077be678903, replyNumber=0, likeNumber=61, createdTime=2016-09-08, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=077be678903, moduleTitle=2016头颈部鳞状细胞癌颈淋巴结转移处理的专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=077be678903)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297675, encodeId=80c2129e6752e, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Cancer：口腔卫生会影响HPV相关头颈部鳞状细胞癌的患病风险吗？, objectType=article, longId=76315, objectId=7202e63153b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7202e63153b, replyNumber=0, likeNumber=101, createdTime=2016-09-01, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7202e63153b, moduleTitle=Cancer：口腔卫生会影响HPV相关头颈部鳞状细胞癌的患病风险吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7202e63153b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297674, encodeId=4d53129e67494, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=百时美PD-1免疫疗法Opdivo关键III期临床治疗头颈部鳞状细胞癌（SCCHN）大获成功, objectType=article, longId=66959, objectId=0eb56695937, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0eb56695937, replyNumber=0, likeNumber=89, createdTime=2016-04-23, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0eb56695937, moduleTitle=百时美PD-1免疫疗法Opdivo关键III期临床治疗头颈部鳞状细胞癌（SCCHN）大获成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0eb56695937)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297673, encodeId=a2ce129e673f0, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Clin Cancer Res：MEK抑制剂单独或联合mTOR抑制剂对头颈部鳞状细胞癌的抗肿瘤作用, objectType=article, longId=50869, objectId=694b508695d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=694b508695d, replyNumber=0, likeNumber=95, createdTime=2015-05-19, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=694b508695d, moduleTitle=Clin Cancer Res：MEK抑制剂单独或联合mTOR抑制剂对头颈部鳞状细胞癌的抗肿瘤作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=694b508695d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297672, encodeId=5c6f129e6724e, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=Invest New Drugs：dacomitinib(pan-HER 抑制剂)用于晚期头颈部鳞状细胞癌的药代动力学评价, objectType=article, longId=50462, objectId=d8575046299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8575046299, replyNumber=0, likeNumber=91, createdTime=2015-05-10, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8575046299, moduleTitle=Invest New Drugs：dacomitinib(pan-HER 抑制剂)用于晚期头颈部鳞状细胞癌的药代动力学评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8575046299)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1297671, encodeId=6fda129e671f0, content=<a href='/topic/show?id=f999444352f' target=_blank style='color:#2F92EE;'>#头颈部鳞状细胞癌#</a>, objectTitle=ASCO 2014：高危头颈部鳞状细胞癌辅助术后拉帕替尼同步放化疗不增加DFS, objectType=article, longId=35256, objectId=6ba335256be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ba335256be, replyNumber=0, likeNumber=70, createdTime=2014-05-25, rootId=0, userName=Smile2680, userId=c48a270, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ba335256be, moduleTitle=ASCO 2014：高危头颈部鳞状细胞癌辅助术后拉帕替尼同步放化疗不增加DFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ba335256be)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

头颈部鳞状细胞癌

2020-05-29

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

CLIN CANCER RES：NOTCH4-HEY1通路诱导头颈部鳞状细胞癌上皮间质化

2018-02-27

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Ann Oncol：顺铂+西妥昔单抗+再放疗对于复发性或第二原发性头颈部鳞状细胞癌患者可行

2018-01-21

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Ann Oncol：顺铂+西妥昔单抗+再放疗对于复发性或第二原发性头颈部鳞状细胞癌患者可行

2018-01-21

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Oral Oncol：头颈部鳞状细胞癌突变的主要来源-APOBEC

2017-11-21

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

BJC：SKLB188抑制头颈部鳞状细胞癌生长

2017-09-08

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Eur Radiol：FDG-PET/MRI联合DWI检出头颈部鳞状细胞癌放化疗后局部复发的价值

2017-08-28

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Lancet Oncol：纳武单抗：复发性/转移性头颈部鳞状细胞癌患者的福音？

2017-08-23

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Ann Oncol：局部晚期头颈部鳞状细胞癌的HPV状态是否能决定其有效化疗方案（EORTC 24971研究的亚组分析）

2017-07-28

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

CLIN CHEM：血液中的游离循环甲基化DNA用于头颈部鳞状细胞癌患者的诊断，分期，预后和监测

2017-07-28

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

CLIN CANCER RES：c-Fos可以增强头颈部鳞状细胞癌肿瘤干细胞样细胞特性

2017-07-06

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

CLIN CANCER RES：Motolimod联合西妥昔单抗治疗复发或转移性头颈部鳞状细胞癌

2017-05-28

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

JAMA Oncology：头颈部鳞状细胞癌KRAS变异与西妥昔单抗反应

2017-05-10

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

百时美Opdivo获欧盟CHMP推荐批准，将成欧洲治疗头颈部鳞状细胞癌（SCCHN）的肿瘤免疫疗法

2017-03-31

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

2016 CCO指南：头颈部鳞状细胞癌的系统治疗

2016-11-13

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

2016头颈部鳞状细胞癌颈淋巴结转移处理的专家共识发布

2016-09-08

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Cancer：口腔卫生会影响HPV相关头颈部鳞状细胞癌的患病风险吗？

2016-09-01

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

百时美PD-1免疫疗法Opdivo关键III期临床治疗头颈部鳞状细胞癌（SCCHN）大获成功

2016-04-23

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Clin Cancer Res：MEK抑制剂单独或联合mTOR抑制剂对头颈部鳞状细胞癌的抗肿瘤作用

2015-05-19

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

Invest New Drugs：dacomitinib(pan-HER 抑制剂)用于晚期头颈部鳞状细胞癌的药代动力学评价

2015-05-10

Smile2680 (审核中...)

前往app查看评论内容

#头颈部鳞状细胞癌#

ASCO 2014：高危头颈部鳞状细胞癌辅助术后拉帕替尼同步放化疗不增加DFS

2014-05-25

科室
- - 订阅+
  - 更多科室
工具
服务